These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 19284394

  • 1. Effects of aggressive approach to the multiple risk factors for diabetic nephro-pathy on proteinuria reduction in diabetes type 2 patients.
    Ascić-Buturović B, Kacila M, Kulić M.
    Bosn J Basic Med Sci; 2009 Feb; 9(1):44-8. PubMed ID: 19284394
    [Abstract] [Full Text] [Related]

  • 2. Effects of basal insulin analog and metformin on glycaemia control and weight as risk factors for endothelial dysfunction.
    Ascić-Buturović B, Kacila M.
    Bosn J Basic Med Sci; 2008 Nov; 8(4):309-12. PubMed ID: 19125700
    [Abstract] [Full Text] [Related]

  • 3. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial.
    Slagman MC, Waanders F, Hemmelder MH, Woittiez AJ, Janssen WM, Lambers Heerspink HJ, Navis G, Laverman GD, HOlland NEphrology STudy Group.
    BMJ; 2011 Jul 26; 343():d4366. PubMed ID: 21791491
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Retarding the progression of diabetic nephropathy in type 2 diabetes mellitus: focus on hypertension and proteinuria.
    Lee GS.
    Ann Acad Med Singap; 2005 Jan 26; 34(1):24-30. PubMed ID: 15726216
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Risk and prevention of diabetic nephropathy].
    Ravera M, Re M, Deferrari G.
    G Ital Nefrol; 2007 Jan 26; 24 Suppl 38():13-9. PubMed ID: 17922442
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group.
    Ostman J, Asplund K, Bystedt T, Dahlöf B, Jern S, Kjellström T, Lithell H.
    J Intern Med; 1998 Aug 26; 244(2):95-107. PubMed ID: 10095796
    [Abstract] [Full Text] [Related]

  • 15. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar 26; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High incidence of diabetic nephropathy in early-onset Japanese NIDDM patients. Risk analysis.
    Yokoyama H, Okudaira M, Otani T, Watanabe C, Takaike H, Miuira J, Yamada H, Mutou K, Satou A, Uchigata Y, Iwamoto Y.
    Diabetes Care; 1998 Jul 26; 21(7):1080-5. PubMed ID: 9653599
    [Abstract] [Full Text] [Related]

  • 20. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR, Jalomo-Martínez B, Cortés-Sanabria L, Rojas-Campos E, Barragán G, Alfaro G, Cueto-Manzano AM.
    Am J Kidney Dis; 2006 Jan 26; 47(1):78-87. PubMed ID: 16377388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.